Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Phase 3, Multi Center, Single-arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) Ligand in Men With Newly Diagnosed Prostate Cancer

Next Previous
Trial Profile

A Prospective, Phase 3, Multi Center, Single-arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) Ligand in Men With Newly Diagnosed Prostate Cancer

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluorine 18 flotufolastat (Primary)
  • Indications Adenocarcinoma; Cancer metastases; Prostate cancer
  • Focus Diagnostic use; Registrational
  • Acronyms LIGHTHOUSE
  • Sponsors Blue Earth Diagnostics

Most Recent Events

  • 08 May 2024 According to a Blue Earth Diagnostics media release, the signing of a non-exclusive data-sharing agreement with Siemens Healthineers for anonymized POSLUMA (flotufolastat F 18) injection (formerly known as 18F-rhPSMA-7.3) clinical data and images from Blue Earth Diagnostics Phase 3 LIGHTHOUSE trial in newly diagnosed prostate cancer.
  • 28 Nov 2023 According to Blue Earth Diagnostics media release, results of a post-hoc analysis from this and SPOTLIGHT studies will appear in an upcoming print issue of molecular imaging and biology.
  • 28 Nov 2023 According to Blue Earth Diagnostics media release, results from this and SPOTLIGHT studies, were published online in Molecular Imaging and Biology (2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top